IP Library › Granted Patent US 9,139,849

Granted Patent B2

US 9,139,849 · App. 11/910,973 · Granted Sep 22, 2015

Rapid generation of long synthetic centromeric tandem repeats for mammalian artificial chromosome formation

Inventors: Vladimir L. Larionov (Potomac, MD); William C. Earnshaw (Cingletie Peeples, GB); Reto Gassman (Zurich, CH); Stefanie Kandels-Lewis (Dielheim-Balzfeld, DE); Hiroshi Masumoto (Rockville, MD); Megumi Nakano (Rockville, MD); Vladimir Noskov (Rockville, MD); Natalay Y. Kouprina (Potomac, MD); Carl J. Barrett (Chapel Hill, NC); Stefano Cardinale (Edinburgh, GB)

Assignees: The United States of America as Represented by the Government of the Department of Health and Human Services; The University Court of the University of Edinburgh

C12N15/85 C12N2800/204 C12N2800/206 C12N2800/208 C12N2830/003

View Patent ↗

Loading inventors, assignments & file history…

Monitor This Case

Get email alerts when status or documents change.

Order Certified Copies

Most orders are placed with the USPTO same day — all within 24 business hours.

Order via The Patent Place →

Pre-filled with this patent's details

Quick Facts

Patent No.: US 9,139,849
App. No.: 11/910,973
Granted: Sep 22, 2015
Kind: B2

External Links

USPTO Patent Center↗ Full Patent PDF↗

Abstract

Methods are described for construction of long synthetic arrays of DNA repeats, such as alphoid repeats or other repeat sequences. The methods include concatamerization of DNA into short repeats (for instance using rolling circle amplification or directional in vitro ligation), followed by assembling the short repeats into long arrays by homologous recombination during transformation into microbe cells. These methods can be described generally as Recombinational Amplification of Repeats (RAR). The long arrays are engineered centromere-like regions that allow one to construct mammalian artificial chromosomes with a predefined centromeric region structure. Artificial chromosomes, including human artificial chromosomes with a regulated centromere, and methods of their use are also provided.

Claims (55)

1. A method of generating a mammalian artificial chromosome (MAC) having a regulated centromere, comprising:

assembling one or more engineered centromeric sequences into a vector, wherein the engineered centromeric sequence comprises (1) at least one mammalian repeat sequence comprising an alphoid repeat sequence, a mouse minor satellite sequence or a synthetic sequence at least 90% identical to such a repeat sequence; and (2) a tet Operator (tetO) sequence wherein binding of a transactivator to the tetO sequence disrupts the function of the centromere of the MAC.

2. The method of claim 1 , wherein assembling one or more engineered centromeric sequences comprises homologous in vivo recombination.

3. The method of claim 2 , wherein the homologous in vivo recombination is yeast homologous recombination.

4. The method of claim 2 , wherein the vector is a transformation-associated recombination (TAR) vector comprising:

a yeast cassette, comprising:

a yeast origin of replication; and

a yeast selectable marker sequence;

a mammalian marker sequence; and

a sequence containing hooks homologous to sequence within the mammalian repeat sequence.

5. The method of claim 4 , wherein the hooks comprise at least 30 contiguous nucleotides at least 90% homologous to a sequence selected from an alphoid repeat, or a mouse minor satellite.

6. The method of claim 4 , wherein the TAR vector further comprises:

a bacterial origin of replication; and

a bacterial selectable marker sequence.

7. The method of claim 1 , wherein the engineered centromeric sequence is produced by rolling circle amplification (RCA) of a starting sequence to produce a RCA product which is the engineered centromeric sequence, wherein the RCA product is a mixture of different lengths of concatamerized repeat sequence.

8. The method of claim 7 , wherein the RCA products:

average about 1 to about 5 kb in length;

average about 1 to about 10 kb in length;

average more than 2 kb in length;

average about 5 kb in length; or

average more than 5 kb in length.

9. The method of claim 7 , wherein the number of RCA products assembled into the artificial chromosome form a centromeric region of:

at least 10 kb;

at least 20 kb;

at least 50 kb;

at least 70 kb;

at least 80 kb;

at least 100 kb; or

more than 100 kb.

10. A method of making a mammalian artificial chromosome having a regulated centromere competent for maintenance in a mammalian cell, comprising:

selecting a starting sequence comprising (1) at least one mammalian repeat sequence comprising an alphoid repeat sequence, a mouse minor satellite sequence or a synthetic sequence at least 90% identical to such a repeat sequence; and (2) a tet Operator (tetO) sequence;

amplifying the starting sequence into a tandem repeat sequence using rolling-circle amplification; and

capturing the tandem repeat sequence in a nucleic acid molecule using in vivo homologous recombination to produce a mammalian artificial chromosome,

wherein the centromere of the mammalian artificial chromosome comprises the tandem repeat sequence, and

wherein the mammalian artificial chromosome is competent for maintenance in a mammalian cell; and wherein binding of a transactivator to the tetO sequence disrupts the function of the centromere of the MAC.

11. The method of claim 10 , wherein the nucleic acid molecule is a TAR vector.

12. A mammalian artificial chromosome (MAC), made by the method of claim 1 .

13. The MAC of claim 12 , further comprising an expression cassette containing at least one mammalian protein encoding sequence.

14. A mammalian artificial chromosome (MAC), made by the method of claim 10 .

15. The MAC of claim 14 , further comprising an expression cassette containing at least one mammalian protein encoding sequence.

16. The method of claim 10 , wherein amplifying the starting sequence into a tandem repeat sequence using rolling-circle amplification comprises producing a RCA product comprising the tandem repeat sequence amplified from the starting sequence using rolling-circle amplification, wherein the RCA product is a mixture of different lengths of concatamerized starting sequence.

17. The method of claim 16 , wherein the RCA products: